EquityZen Growth Technology Fund LLC - Series 2311
Raised
$448K
Investors
—
Min Invest
$0
AltStreet Analysis
·Generated from EDGAR primary sources
EquityZen Growth Technology Fund LLC - Series 2311 is a private equity vehicle filed on 2026-06-12 under exemptions 506(b), 506(c), Rule 504, and 4(a)(5). This is a pre-open filing with no disclosed capital raised, investor count, or minimum investment. It is part of the EquityZen platform, which has 168 related EDGAR entities offering access to private company shares through individual series SPVs.
This filing represents a typical pre-launch structure in the private equity category, utilizing multiple exemption types (506(b), 506(c), Rule 504, 4(a)(5)) to preserve flexibility for both accredited and potentially non-accredited investors. The EquityZen series model creates separate SPVs for individual private company investment opportunities, consistent with secondary marketplace platforms in the growth technology sector.
Data Flags
EDGAR Filing Data
Form D — Primary Source
View on SEC.govIs this your offering?
Claim this profile to add contact information, team members, LinkedIn profiles, fund history, and additional financial data. EDGAR-sourced data and AltStreet analysis cannot be edited, but corrections can be requested for verifiable inaccuracies.
Data Methodology
Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.
